Lâle Tokgözoğlu

4 ta ish

Department of Cardiology, Hacettepe University, Ankara, Turkey

1. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20181 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000004

2. The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms

   Bilge Volkan Salancı, Hakan Aksoy, Pınar Özgen Kıratlı +6

   MaqolaChemotherapy-induced cardiotoxicity and mitigationJournal of Chemotherapy20120 iqtibos

   ABIABI:AkademIndex/openalex/2012.article.000042

3. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

   Richard Češka, Tomáš Freiberger, Andrey V. Susekov +26

   MaqolaLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos

   ABIABI:AkademIndex/openalex/2017.article.000199

4. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

   Richard Češka, György Paragh, Željko Reiner +26

   MaqolaLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos

   ABIABI:AkademIndex/openalex/2017.article.000270